Online first
Clinical vignette
Published online: 2024-11-12
First-in-Poland thoracoscopic left atrial appendage closure using Novel AtriClip® PRO-V device in patient with previous heart surgery and LAA thrombus
Pubmed: 39535944
Abstract
Not available
References
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991; 22(8): 983–988.
- Van Gelder IC, Rienstra M, Bunting KV, et al. et al.. ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024; 45(36): 3314–3414.
- Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021; 52(7): e364–e467.
- Perreault S, de Denus S, White-Guay B, et al. Oral anticoagulant prescription trends, profile use, and determinants of adherence in patients with atrial fibrillation. Pharmacotherapy. 2020; 40(1): 40–54.
- Kowalewski M, Wańha W, Litwinowicz R, et al. Stand-Alone left atrial appendage occlusion for throMboembolism prevention in nonvalvular atrial fibrillatioN disease registry (SALAMANDER): protocol for a prospective observational nationwide study. BMJ Open. 2022; 12(9): e063990.
